• Experience in conducting global clinical trials by managing multi-functional international study teams in adherence to ICH Guidelines and other applicable regulations
  • Expertise in the design, feasibility assessment, and planning of single and multi-center Phase I-IV clinical trials
  • Experience in compiling and writing technical documents such as investigational drug brochures, protocols, informed consents, and clinical study reports
  • Expertise in qualifying, selecting, training, managing field-based study monitors and medical monitors against clinical trial needs
  • Expertise in creating and implementing Monitoring, Audit, Data Management, and Trial Master File plans
  • Expertise in investigational drug accountability procedures including for controlled substances

MSA News

Progress During the Pandemic

August 31, 2020 – Our surviving the Covid-19 experience has been an example of what having a great team can…

Read More

MSA and COVID-19

Frederick, MD July 17, 2020 – MSA has decided to delay the full-time return to our Frederick offices indefinitely.  Unfortunately,…

Read More

Mesa Science Associates and Bryn Pharma Publish Final of Three Pre-Clinical Studies of a New Approach to Treating Anaphylaxis

The third in a series of studies measured cerebrospinal fluid epinephrine pharmacokinetics, nasal mucosa effects, plasma epinephrine pharmacokinetics, and cardiovascular…

Read More